Your dog was diagnosed with Oral Squamous Cell Carcinoma. Second most common oral tumour after melanoma. Biological behaviour varies dramatically by location: rostral/gingival SCC has low metastatic rate and good surgical prognosis; tonsillar SCC is highly metastatic with poor prognosis. Compare 4 treatment options for dogs including Mandibulectomy / Maxillectomy (Surgical Excision), Surgery + Adjuvant Radiation, Tonsillar SCC — Radiation ± Chemotherapy — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Oral Squamous Cell Carcinoma
Canine Oncology Treatment Guide
Oral Squamous Cell Carcinoma
WHO TNM staging
Epithelial
About This Cancer
Oral squamous cell carcinoma (SCC) arises from the squamous epithelial cells that line the surfaces of the mouth. Its behaviour varies dramatically depending on location within the oral cavity: tumours in the front of the mouth (rostral gingival SCC) tend to invade bone locally but rarely spread distantly, giving them a good prognosis with surgical removal. In stark contrast, tonsillar SCC is one of the most aggressive oral tumours in dogs, with early and widespread metastasis to lymph nodes and lungs and a very poor prognosis. Tumours at intermediate locations fall somewhere between these extremes. This location-dependent behaviour is a defining feature of oral SCC and directly guides treatment recommendations — what works well for a gingival tumour may not be appropriate for a tonsillar one.
WHO TNM for Canine Oral Tumours
Based on tumour size, lymph node status, and metastasis
Prognostic Factors(3)
Minimum Workup(5 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.